For someone exploring GLP-1 treatment in Singapore, three questions are more useful than a generic price list: Is the exact medicine registered for the relevant use? Who provides medical assessment? What will the complete course of care cost?
Local-language quick guide
中文摘要： 在新加坡了解 GLP-1 治疗时，请通过卫生科学局（HSA）的官方产品登记资料核对药物，并向医疗机构确认诊疗资格、转诊要求及新币总费用。本目录不保证任何特定药品当前获批或有货。
Ringkasan Bahasa Melayu: Semak pendaftaran ubat melalui HSA, pengamal perubatan dan jumlah kos dalam SGD sebelum memulakan perbincangan rawatan. Ketersediaan ubat tidak dijamin oleh direktori ini.
The detailed guide below is currently in English. Other language editions require editorial review before publication.
Where to verify a GLP-1 medicine in Singapore
HSA Infosearch links to the Register of Therapeutic Products. Check the exact trade name, active ingredient and current approved product information; do not assume an overseas brand is registered in Singapore.
Open the official Health Sciences Authority (HSA) resource and keep the product name and registration details with the date checked. Search results can change, and a registration for one brand, indication or presentation should not be extended to another.
GLP-1 medicines are not a single interchangeable group. Semaglutide and tirzepatide have different receptor actions and can have different labels or permitted indications across markets. The WHO’s 2025 guideline discusses these therapies for adults with obesity as part of broader care, rather than a substitute for medical assessment.
Finding weight-management clinics
Our Singapore clinic directory links to documented provider websites rather than asserting that every listed clinic offers a particular prescription. Singapore General Hospital, Khoo Teck Puat Hospital and Tan Tock Seng Hospital are directory starting points for obesity-related services; check referral criteria and current services with each provider.
A useful first contact should establish clinician qualifications, referral requirements, relevant examinations, ongoing reviews, the exact prescribing and dispensing pathway, and how to handle adverse effects or treatment changes.
Understanding GLP-1 costs in SGD
Differentiate public or specialist-hospital assessments, private consultations, blood tests and prescription medicine. An initial visit amount may exclude laboratory or medicine costs, and insurance coverage must be confirmed case by case.
Ask whether referral is required, what is included in the quoted SGD amount, how clinical follow-up works and whether the exact proposed medicine appears in the HSA register.
Use the GLP1Asia treatment cost calculator with quoted fees. It calculates a scenario from your entries; it is not a price database. You can also read how to compare treatment costs.
Which GLP-1 medicines should I compare?
Start with two research summaries: semaglutide in Asia and tirzepatide in Asia. They explain the medicine classes, common consultation questions and why brand registration must be checked country by country. The treatment comparison covers additional agents and research-stage compounds.
Frequently asked questions about GLP-1 in Singapore
How do I verify a GLP-1 medicine in Singapore?
Check the official register published by Health Sciences Authority (HSA), using the exact brand, active ingredient or registration number. A generic website mention is not proof of a specific current registration.
How much does GLP-1 care cost in Singapore?
It depends on the provider and what is included. Ask for itemised consultation, diagnostics, follow-up and any medicine cost in SGD; a screening package is not a medicine price.
Can I find GLP-1 clinics in Singapore?
GLP1Asia lists source-linked obesity or weight-management service references. Confirm with each provider whether a qualified clinician currently offers GLP-1 evaluation and which medicines, if any, are available.
Are semaglutide and tirzepatide the same?
No. Semaglutide acts at the GLP-1 receptor; tirzepatide acts at GIP and GLP-1 receptors. Indications, products, clinical decisions and country-specific registration are not interchangeable.
Does a clinic listing mean GLP1Asia has verified a doctor or product?
No. Listing links show a source for an organisation or service; they are not an independent licence audit or proof of prescribing availability.
How often is information about Singapore checked?
Automated checks may detect website changes, with regulatory sources checked when due and some directory and price sources scheduled weekly. A successful fetch is not proof that clinical information or current product status has been verified.
Primary sources and next checks
- Health Sciences Authority (HSA) — official medicine or regulator information
- World Health Organization — 2025 GLP-1 obesity guideline
- MedlinePlus — semaglutide medicine information
- MedlinePlus — tirzepatide medicine information